Stanford University
Showing 521-530 of 534 Results
-
Allen Wu
Principal Engineer At Eli Lilly And Company, Medicine - Med/Cardiovascular Medicine
BioAllen Wu is a machine learning engineer and researcher specializing in large-scale AI/ML infrastructure for biomedical and pharmaceutical applications. He contributed to the development of TuneLab, an Eli Lilly AI/ML platform supporting federated drug discovery with external biotech partners, and Model Gateway, an MLOps inference platform for internal model-driven drug discovery, during his tenure at Eli Lilly. He holds dual MS degrees in Computer Science (National Chiao Tung University, Taiwan) and Software Engineering (San José State University), with publications in both VLSI/EDA and Pharma AI, and is an IEEE peer reviewer and NSTC LEAP Fellow (hosted at Synopsys). His current research interests focus on the intersection of iPSC biology and AI/ML pipelines for precision medicine.
LinkedIn Profile: https://www.linkedin.com/in/yswu123
Google Scholar Profile: https://scholar.google.com/citations?user=ymttL5gAAAAJ -
Yingcheng Wu
Visiting Postdoctoral Scholar, Pathology
Affiliate, Pathology Research Faculty PTAsBioYingcheng (Charles) Wu is a researcher specializing in Agentic AI for Medicine, advised by Le Cong and Mengdi Wang. Charles has published studies in top-tier journals including Cell, Science, Nature, and Cancer Discovery, and is a recipient of the ICIS Sidney & Joan Pestka Award, the IUBMB Young Scientist Program Fellowship, and the APASL Young Investigator Award.
-
Yue Wu
Postdoctoral Scholar, Genetics
Current Research and Scholarly InterestsI built computational methods to integrate and model biological time series, including metabolic dynamics, longitudinal multi-omics data, and micro-sampling. I reduce dimensions, built clusters, and search for causal links.
-
Courtney Wusthoff, MD
Member, Maternal & Child Health Research Institute (MCHRI)
Current Research and Scholarly InterestsMy projects focus on clinical research in newborns with, or at risk, for brain injury. I use EEG in at-risk neonates to better understand the underlying pathophysiology of risk factors that may lead to worse outcomes. I am particularly interested in neonatal seizures and how they may exacerbate perinatal brain injury with a goal to identify treatments that might protect the vulnerable brain. I am also interested in EEG in other pediatric populations, as well as medical ethics and global health.